LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | OSI-027 | 1.11 | uM | LJP6 | 1 | E09 | 72 | hr | 2543 | 2321 | 5578 | 0.4161 | -0.0733 |
| SK-BR-3 | OSI-027 | 1.11 | uM | LJP6 | 2 | E09 | 72 | hr | 2543 | 2180 | 5578 | 0.3908 | -0.1198 |
| SK-BR-3 | OSI-027 | 1.11 | uM | LJP6 | 3 | E09 | 72 | hr | 2543 | 2323 | 5578 | 0.4164 | -0.0726 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 1 | P21 | 72 | hr | 2543 | 4417 | 5578 | 0.7918 | 0.6173 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 2 | P21 | 72 | hr | 2543 | 4607 | 5578 | 0.8258 | 0.6799 |
| SK-BR-3 | XMD11-85h | 1.11 | uM | LJP6 | 3 | P21 | 72 | hr | 2543 | 4452 | 5578 | 0.7980 | 0.6288 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 2543 | 4608 | 5578 | 0.8260 | 0.6802 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 2543 | 4073 | 5578 | 0.7301 | 0.5039 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 2543 | 4557 | 5578 | 0.8169 | 0.6634 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 1 | O09 | 72 | hr | 2543 | 5172 | 5578 | 0.9271 | 0.8660 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 2 | O09 | 72 | hr | 2543 | 5300 | 5578 | 0.9501 | 0.9082 |
| SK-BR-3 | WH-4-025 | 1.11 | uM | LJP5 | 3 | O09 | 72 | hr | 2543 | 5309 | 5578 | 0.9517 | 0.9112 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 1 | J21 | 72 | hr | 2543 | 2728 | 5578 | 0.4890 | 0.0608 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 2 | J21 | 72 | hr | 2543 | 2978 | 5578 | 0.5338 | 0.1432 |
| SK-BR-3 | WZ-4-145 | 1.11 | uM | LJP6 | 3 | J21 | 72 | hr | 2543 | 3003 | 5578 | 0.5383 | 0.1514 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 2543 | 2201 | 5578 | 0.3945 | -0.1128 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 2 | M09 | 72 | hr | 2543 | 2091 | 5578 | 0.3748 | -0.1491 |
| SK-BR-3 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 2543 | 2184 | 5578 | 0.3915 | -0.1184 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 2543 | 5260 | 5578 | 0.9429 | 0.8950 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 2543 | 4815 | 5578 | 0.8631 | 0.7484 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 2543 | 5573 | 5578 | 0.9990 | 0.9981 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 2543 | 1456 | 5578 | 0.2610 | -0.3583 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 2543 | 1317 | 5578 | 0.2361 | -0.4041 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 2543 | 1587 | 5578 | 0.2845 | -0.3151 |
| SK-BR-3 | BX-912 | 1.11 | uM | LJP5 | 1 | L21 | 72 | hr | 2543 | 2024 | 5578 | 0.3628 | -0.1711 |